| Literature DB >> 30233803 |
Mika Takeuchi1, Ayaka Tsuboi2,3, Satomi Minato2,4, Megumu Yano2, Kaori Kitaoka2,5, Miki Kurata1,5, Tsutomu Kazumi2,6, Keisuke Fukuo1,2.
Abstract
OBJECTIVE: To determine if adiponectin levels are associated with low grip strength among the elderly independently of insulin resistance and inflammation. RESEARCH DESIGN AND METHODS: Cross-sectional associations were analyzed by logistic regression between low grip strength and body composition, elevated serum adiponectin (≥20 mg/L), and biomarkers of nutritious stasis, insulin resistance and inflammation in 179 community-living Japanese women. Sarcopenia was evaluated using the Asian criteria.Entities:
Keywords: adiponectin; elderly women; grip strength; inflammation; insulin resistance; muscle mass; transthyretin
Year: 2018 PMID: 30233803 PMCID: PMC6135424 DOI: 10.1136/bmjdrc-2018-000537
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Anthropometric and laboratory characteristics of 179 women stratified by the presence or absence of low grip strength (<18.0 kg)
| Low grip strength | P values | ||
| Yes (n=68) | No (n=111) | ||
| Age (years) | 81.1±5.5 | 74.2±8.7 | <0.001 |
| Height (cm) | 145.2±5.3 | 151.2±5.6 | <0.001 |
| Weight (kg) | 46.1±7.2 | 52.3±7.0 | <0.001 |
| BMI (kg/m2) | 21.9±3.3 | 22.9±2.8 | 0.037 |
| Fat mass index (kg/m2) | 7.0±2.7 | 7.6±2.2 | 0.139 |
| SMI (kg/m2) | 7.9±1.1 | 7.9±0.8 | 0.757 |
| Waist circumference (cm) | 85.0±10.0 | 87.5±8.9 | 0.087 |
| Fat mass (kg) | 14.7±5.7 | 17.2±5.1 | 0.003 |
| Percentage body fat (%) | 31.0±7.9 | 32.4±6.5 | 0.201 |
| Skeletal muscle mass (kg) | 16.5±1.9 | 18.1±2.0 | <0.001 |
| Grip strength (kg) | 15.0±2.6 | 23.4±3.7 | <0.001 |
| PB glucose (mg/dL) | 102±39 | 99±23 | 0.451 |
| PB insulin (μU/mL) | 9.6±9.2 | 7.2±5.3 | 0.114 |
| PB triglycerides (mg/dL) | 137±72 | 142±84 | 0.700 |
| Cholesterol (mg/dL) | 214±29 | 222±34 | 0.104 |
| HDL cholesterol (mg/dL) | 61±13 | 65±14 | 0.086 |
| Leptin (ng/mL) | 7.3±5.1 | 8.0±4.6 | 0.375 |
| Adiponectin (mg/L) | 16.5±9.7 | 12.7±6.4 | 0.004 |
| Leukocytes (103/μL) | 6.1±1.5 | 6.1±1.6 | 0.951 |
| PAI-1 (ng/mL) | 23±11 | 25±12 | 0.378 |
| hsCRP (μg/dL) | 85±103 | 86±115 | 0.938 |
| TNF-α (pg/mL) | 1.8±0.9 | 1.5±1.1 | 0.008 |
| Red blood cells (104/μL) | 414±40 | 429±33 | 0.008 |
| Hemoglobin (g/dL) | 12.6±1.1 | 13.1±1.1 | 0.005 |
| Hematocrit (%) | 40.1±3.4 | 41.3±3.3 | 0.014 |
| Albumin (g/dL) | 4.30±0.28 | 4.45±0.23 | <0.001 |
| Iron (μg/dL) | 90±29 | 96±27 | 0.165 |
| Copper (μg/dL) | 110±17 | 108±14 | 0.337 |
| Zinc (μg/dL) | 74±11 | 78±11 | 0.007 |
| Transthyretin (mg/dL) | 25±5 | 28±5 | <0.001 |
| Creatinine (mg/dL) | 0.69±0.18 | 0.69±0.14 | 0.983 |
| eGFR (mL/min/1.73 m2) | 64±13 | 65±13 | 0.601 |
| Anemia (n, %) | 17, 25.0 | 19, 17.1 | 0.184 |
| CKD G3b (n, %) | 7, 10.3 | 6, 5.4 | 0.246 |
| Hyperadiponectinemia | 21, 30.9 | 16, 14.4 | 0.008 |
Mean±SD or n, %.
BMI, body mass index; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate;hsCRP, high-sensitivity C reactive protein;PAI-1, plasminogen activator-inhibitor-1; PB, postbreakfast;SMI, skeletal muscle mass index;TNF-α, tumor necrosis factor-α.
Bivariate (A) and multivariate (B and C) logistic regression analyses for low grip strength as a dependent variable
| OR | 95% CI | P values | |
| Model A | |||
| Age | 1.14 | 1.08 to 1.21 | <0.001 |
| Height | 0.81 | 0.75 to 0.87 | <0.001 |
| Weight | 0.88 | 0.83 to 0.93 | <0.001 |
| Fat mass | 0.91 | 0.86 to 0.97 | 0.004 |
| Skeletal muscle mass | 0.64 | 0.53 to 0.77 | <0.001 |
| Adiponectin (mg/L) | 1.07 | 1.02 to 1.11 | 0.003 |
| Log TNF-α | 6.40 | 1.58 to 25.93 | 0.009 |
| Hemoglobin | 0.67 | 0.50 to 0.89 | 0.006 |
| Albumin | 0.08 | 0.02 to 0.30 | <0.001 |
| Transthyretin | 0.88 | 0.83 to 0.95 | <0.001 |
| Zinc | 0.96 | 0.93 to 0.99 | 0.008 |
| Hyperadiponectinemia | 2.65 | 1.27 to 5.55 | 0.010 |
| Model B | |||
| Age | 1.10 | 1.03 to 1.17 | 0.007 |
| Height | 0.84 | 0.77 to 0.91 | <0.001 |
| Skeletal muscle mass | 0.74 | 0.59 to 0.92 | 0.008 |
| Transthyretin | 0.90 | 0.83 to 0.97 | 0.010 |
| Model C | |||
| Age | 1.09 | 1.02 to 1.16 | 0.010 |
| Height | 0.86 | 0.79 to 0.94 | 0.001 |
| Weight | 0.93 | 0.87 to 0.99 | 0.022 |
| Skeletal muscle mass | 0.78 | 0.62 to 0.97 | 0.028 |
| Log TNF-α | 7.70 | 1.30 to 45.8 | 0.025 |
Model A included all variables that showed significant differences between women with and without low grip strength in table 1. Model B included all variables in model A, except for adiponectin, as independent variables. In model C, adiponectin and transthyretin were removed from model A.
PB, postbreakfast;TNF-α, tumor necrosis factor-α.
Anthropometric and laboratory characteristics of 179 women stratified by the presence or absence of hyperadiponectinemia (≥20 mg/L)BMI, body mass index; HDL, high-density lipoprotein; SMI, skeletal muscle mass index.
| Hyperadiponectinemia | P values | ||
| No (n=142) | Yes (n=37) | ||
| Adiponectin (mg/L) | 10.9±4.3 | 26.4±6.9 | <0.001 |
| Age (years) | 76±8 | 80±8 | 0.011 |
| Grip strength (kg) | 20.8±5.3 | 17.9±4.9 | 0.003 |
| Low grip strength (n, %) | 47,33.1 | 21,56.8 | 0.008 |
| Skeletal muscle mass (kg) | 17.6±2.2 | 17.2±1.9 | 0.296 |
| SMI (kg/m2) | 7.9±0.9 | 8.0±1.0 | 0.416 |
| BMI (kg/m2) | 23.0±2.9 | 20.4±2.8 | <0.001 |
| Fat mass index (kg/m2) | 7.8±2.3 | 5.5±2.1 | <0.001 |
| Waist circumference (cm) | 88.2±8.9 | 80.6±8.8 | <0.001 |
| Leptin (ng/mL) | 8.5±4.9 | 4.8±2.9 | <0.001 |
| PB glucose (mg/dL) | 102±32 | 94±18 | 0.122 |
| PB insulin (μU/mL) | 8.8±7.4 | 4.8±4.0 | 0.001 |
| PB triglycerides (mg/dL) | 151±83 | 96±41 | <0.001 |
| Cholesterol (mg/dL) | 220±33 | 217±28 | 0.627 |
| HDL cholesterol (mg/dL) | 62±13 | 72±15 | <0.001 |
| Leukocytes (103/μL) | 6.3±1.5 | 5.3±1.4 | <0.001 |
| PAI-1 (ng/mL) | 26±12 | 19±7 | <0.001 |
| hsCRP (μg/dL) | 91±116 | 65±85 | 0.037 |
| TNF-α (pg/mL) | 1.7±1.1 | 1.5±0.8 | 0.415 |
Mean±SD or n, %.
BMI, body mass index; HDL, high-density lipoprotein; hsCRP, high-sensitivity C reactive protein; PAI-1, plasminogen activator-inhibitor-1; PB, postbreakfast; SMI, skeletal muscle mass index; SMI, skeletal muscle mass index.